Výsledky vyhledávání - "Andrew J, Cutler"

Akademický článek

Serdexmethylphenidate/dexmethylphenidate for children with attention-deficit/hyperactivity disorder: dose optimization from a laboratory classroom study

Autor: Andrew J. Cutler, Scott H. Kollins, Matthew N. Brams, Meg Corliss, Charles Oh, Rene Braeckman, Ann C. Childress

Publikováno v: Frontiers in Psychiatry, Vol 15 (2024)

ObjectiveTo evaluate treatment responder rate using the Attention-Deficit/Hyperactivity Disorder Rating Scale-5 (ADHD-RS-5) score based on optimized dose level of serdexmethylphenidate/dexmethylphenidate (SDX/d-MPH) and changes in ADHD severity in ch

Externí odkaz: https://doaj.org/article/9df65ce3c2874ac88d12e6b98ba5c9f5

Zobrazit plný text záznamu

Akademický článek

Understanding the mechanism of action and clinical effects of neuroactive steroids and GABAergic compounds in major depressive disorder

Autor: Andrew J. Cutler, Gregory W. Mattingly, Vladimir Maletic

Publikováno v: Translational Psychiatry, Vol 13, Iss 1, Pp 1-16 (2023)

Abstract The pathophysiology of major depressive disorder (MDD) is thought to result from impaired connectivity between key brain networks. Gamma-aminobutyric acid (GABA) is the key inhibitory neurotransmitter in the brain, working primarily via GABA

Externí odkaz: https://doaj.org/article/68754b99e0274125a9655f0b3a197458

Zobrazit plný text záznamu

Akademický článek

Impact of possible tardive dyskinesia on physical wellness and social functioning: results from the real-world RE-KINECT study

Autor: Caroline M. Tanner, Stanley N. Caroff, Andrew J. Cutler, William R. Lenderking, Huda Shalhoub, Véronique Pagé, Ericha G. Franey, Michael Serbin, Chuck Yonan

Publikováno v: Journal of Patient-Reported Outcomes, Vol 7, Iss 1, Pp 1-11 (2023)

Abstract Background Tardive dyskinesia (TD) is a persistent and potentially disabling movement disorder associated with antipsychotic use. Data from RE-KINECT, a real-world study of antipsychotic-treated outpatients, were analyzed to assess the effec

Externí odkaz: https://doaj.org/article/7624d1f68f3346d79bebd79e645eff49

Zobrazit plný text záznamu

Akademický článek

Serdexmethylphenidate/dexmethylphenidate effects on sleep in children with attention-deficit/hyperactivity disorder

Autor: Greg W. Mattingly, Ann C. Childress, Andrew J. Cutler, José Estrada, Meg Corliss

Publikováno v: Frontiers in Psychiatry, Vol 14 (2023)

IntroductionSleep-related problems are common in children with attention-deficit/hyperactivity disorder (ADHD). Sleep disorders are also side effects of all stimulant ADHD medications. Serdexmethylphenidate/dexmethylphenidate (SDX/d-MPH) is a once-da

Externí odkaz: https://doaj.org/article/2f4c4b00c70e4288afa6b4cec24dfce0

Zobrazit plný text záznamu

Analysis of Growth Velocity in Children with Attention-Deficit/Hyperactivity Disorder Treated for up to 12 Months with Serdexmethylphenidate/Dexmethylphenidate

Autor: Ann C. Childress, Andrew J. Cutler, Maitrey Patel, Charles Oh

Publikováno v: Journal of Child and Adolescent Psychopharmacology. 33:134-142

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::09716daca4775668baf33fe16c17c4fe
https://doi.org/10.1089/cap.2023.0012

Zobrazit plný text záznamu

The efficacy of lumateperone on symptoms of depression in bipolar I and bipolar II disorder: Secondary and post hoc analyses

Autor: Roger S. McIntyre, Suresh Durgam, Susan G. Kozauer, Richard Chen, Jason Huo, Robert E. Davis, Andrew J. Cutler

Publikováno v: European Neuropsychopharmacology. 68:78-88

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::28e978d56ce6917e7f8731e04b123006
https://doi.org/10.1016/j.euroneuro.2022.12.012

Zobrazit plný text záznamu

Safety and Tolerability of Serdexmethylphenidate/Dexmethylphenidate Capsules in Children with Attention-Deficit/Hyperactivity Disorder: A 12-Month, Open-Label Safety Study

Autor: Ann C. Childress, Andrea Marraffino, Andrew J. Cutler, Charles Oh, Matthew N. Brams

Publikováno v: Journal of Child and Adolescent Psychopharmacology. 33:51-58

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8a70404c27c51ab7800f4ded7f16f4cf
https://doi.org/10.1089/cap.2022.0076

Zobrazit plný text záznamu

Akademický článek

A novel digital intervention for actively reducing severity of paediatric ADHD (STARS-ADHD): a randomised controlled trial

Autor: Scott H Kollins, ProfPhD, Denton J DeLoss, PhD, Elena Cañadas, PhD, Jacqueline Lutz, PhD, Robert L Findling, ProfMD, Richard S E Keefe, ProfPhD, Jeffery N Epstein, ProfPhD, Andrew J Cutler, MD, Stephen V Faraone, ProfPhD

Publikováno v: The Lancet: Digital Health, Vol 2, Iss 4, Pp e168-e178 (2020)

Summary: Background: Attention-deficit hyperactivity disorder (ADHD) is a common paediatric neurodevelopmental disorder with substantial effect on families and society. Alternatives to traditional care, including novel digital therapeutics, have show

Externí odkaz: https://doaj.org/article/22f93deccb38425aa859a9f4892c3a35

Zobrazit plný text záznamu

Akademický článek

The safety and tolerability of cariprazine in long-term treatment of schizophrenia: a post hoc pooled analysis

Autor: Henry A. Nasrallah, Willie Earley, Andrew J. Cutler, Yao Wang, Kaifeng Lu, István Laszlovszky, György Németh, Suresh Durgam

Publikováno v: BMC Psychiatry, Vol 17, Iss 1, Pp 1-13 (2017)

Abstract Background Schizophrenia is a chronic and debilitating neuropsychiatric disorder that often requires long-term pharmacotherapy to manage symptoms and prevent relapse. Cariprazine is a potent dopamine D3 and D2 receptor partial agonist that i

Externí odkaz: https://doaj.org/article/c4e1476cce9d4bc396cf63f0a7667304

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání